Fundraising Fox

Tpsglobal

1 known investors

TPS is a global clinical research solutions company focused on study execution, connecting sponsors, sites, and patients to accelerate enrollment, improve retention, and assure data integrity. It positions itself as distinct from CROs and staffing agencies, offering services to convert sponsor spend into measurable trial outcomes.

Also known as TPS · TPS Global · Transformative Pharmaceutical Solutions · Transformative Pharmaceutical Solutions, LLC

Investors · 1

Company profile

researched Aug 2026

Transformative Pharmaceutical Solutions, LLC, which operates as TPS or TPS Global, is a clinical research solutions company built around study execution. It positions itself as neither a contract research organization nor a staffing agency, but as a partner that connects sponsors, research sites and patients across the clinical research ecosystem. The company describes its offering as innovative, cost-effective solutions intended to turn sponsor spend into measurable outcomes by accelerating enrollment, improving retention, assuring data integrity and reducing waste.

TPS describes its work as providing outsourcing and resourcing solutions for clinical and site operations, including the staffing, resourcing, management and oversight of personnel for research studies. Its named products and services include SiteChoice and RAPTOR. The corporate group comprises Transformative Pharmaceutical Solutions, LLC, headquartered in Pennsylvania and registered in Delaware in the United States; Transformative Pharmaceutical Solutions UK Limited, with registered offices in the United Kingdom; and Transformative Pharmaceutical Solutions Ireland Limited, with registered offices in Ireland.

Business model

TPS provides outsourcing and resourcing solutions for clinical and site operations to trial sponsors, including staffing, resourcing, management and oversight of personnel for research studies, delivered through named services such as SiteChoice and RAPTOR. It frames its value proposition as converting sponsor spend into measurable study outcomes rather than acting as a CRO or staffing agency.

Latest developments

The company's public website is being redeveloped, with a placeholder page stating it is revamping its digital presence to better reflect its focus on study execution.

Full profile — market position, technology, go-to-market, geography

Market position

States it is neither a CRO nor a staffing agency, instead acting as an intermediary connecting sponsors, sites and patients, with an emphasis on enrollment speed, patient retention, data integrity and reduction of waste in study budgets.

Technology

The company operates named service offerings SiteChoice and RAPTOR, which process personal data supplied by users and customers in connection with clinical and site operations.

Go-to-market

Clinical trial sponsors, research sites and, indirectly, trial patients; the company also handles personnel data for employees and contractors staffed onto research studies.

Geography

Operates as a group with a US entity headquartered in Pennsylvania and registered in Delaware, a UK entity with registered offices in the United Kingdom, and an Irish entity with registered offices in Ireland; data practices reflect EU GDPR and UK GDPR requirements.

Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.

Research sources · 3

primary sources listed

3 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Tpsglobal do?
TPS is a global clinical research solutions company focused on study execution, linking sponsors, sites and patients.
Who are Tpsglobal's investors?
Tpsglobal's investors include The Argentum Group.